| abstract |
Methods, kits, and pharmaceutical compositions comprising PI3 kinase inhibitors for treating cancer or hematological disorders are provided. Methods and compositions for treating or preventing cancer or diseases, eg, hematological malignancies, having high expression levels of one or more isoforms of PI3K (eg, PI3K-δ and / or PI3K-γ). And kits. Alternatively, a method of administering an isoform selective PI3K modulator, a composition comprising the modulator, and a kit. [Selection] Figure 1 |